Alphamab Oncology
9966.HK
Hong Kong Stock Exchange7.31
HKD
-0.15
- -
Total Valuation
Alphamab Oncology carries a market capitalization of 7.08B, placing it among publicly traded companies globally.
| Market Cap | 7.08B |
| Enterprise Value | N/A |
Stock Price Statistics
Alphamab Oncology's stock has gained approximately 14.93711% over the past 52 weeks. The 50-day moving average sits at 8.47, while the 200-day moving average is 9.84.
| Beta (5Y) | N/A |
| 52-Week Price Change | 14.93711% |
| 50-Day Moving Average | 8.47 |
| 200-Day Moving Average | 9.84 |
| Average Volume (20 Days) | N/A |